Engineering glucan microparticles for drug delivery systems

Key Points

• Drug delivery systems utilizing glucan microparticles show improved efficacy in treatment applications.
• Key metrics indicate enhanced biocompatibility and drug encapsulation rates with glucan formulations.
• Assessment of glucan microparticle systems employs advanced biocompatibility tests and efficacy measures in vitro.
• This highlights the potential of glucan-based systems to transform drug delivery, calling for further clinical investigations.